Clinical summary

German JenaValve brings innovation to TAVI

JenaValve is proud to bring its 2nd generation transapical TAVI system to market.

Download the
CE trial data

JenaValve, a German, Munich based company, has received CE mark for its 2nd generation transapical Transcatheter Aortic Valve Implantation system.

JenaValve's unique design and state of the art engineering has garnered international recognition and positions the company to become one of the leaders in this highly specialized medical device area.

CE approved as of September 2011, it is now commercially available to heart teams and their patients.

At JenaValve, quality is of overriding importance; it is the mainstay of every aspect of our technology development, design process and device engineering and reflects our outstanding German tradition.